These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4715071)

  • 1. Acid monoamine metabolites in cerebrospinal fluid from patients with presenile dementia (Alzheimer's disease).
    Gottfires CG; Roos BE
    Acta Psychiatr Scand; 1973; 49(3):257-63. PubMed ID: 4715071
    [No Abstract]   [Full Text] [Related]  

  • 2. Parkinsonism-dementia and amyotrophic lateral sclerosis of Guam. Effect of probenecid on monoamine catabolite levels in cerebrospinal fluid.
    Chase RN; Schnur JA; Brody JA; Gordon EK
    Arch Neurol; 1971 Jul; 25(1):9-13. PubMed ID: 5146413
    [No Abstract]   [Full Text] [Related]  

  • 3. [Disturbances of monoamine metabolism in organic presenile and senile dementia].
    Gottfries CG
    Lakartidningen; 1974 Mar; 71(13):1284-5. PubMed ID: 4823610
    [No Abstract]   [Full Text] [Related]  

  • 4. Amine metabolism in the human brain: further evaluation of the probenecid test.
    Korf J; Van Praag HM
    Brain Res; 1971 Dec; 35(1):221-30. PubMed ID: 5134227
    [No Abstract]   [Full Text] [Related]  

  • 5. Cerebrospinal fluid probenecid studies: a reinterpretation.
    Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
    Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid pH and monoamine and glucolytic metabolites in Alzheimer's disease.
    Gottfries CG; Kjällquist A; Pontén U; Roos BE; Sundbärg G
    Br J Psychiatry; 1974 Mar; 124(0):280-7. PubMed ID: 4836896
    [No Abstract]   [Full Text] [Related]  

  • 7. Acid monoamine metabolites in the cerebrospinal fluid of patients with Parkinson's disease.
    Rinne UK; Sonninen V
    Neurology; 1972 Jan; 22(1):62-7. PubMed ID: 4550499
    [No Abstract]   [Full Text] [Related]  

  • 8. REM sleep and central monoamine oxidase inhibition.
    Kupfer DJ; Bowers MB
    Psychopharmacologia; 1972; 27(3):183-90. PubMed ID: 4345178
    [No Abstract]   [Full Text] [Related]  

  • 9. Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain.
    Moir AT; Ashcroft GW; Crawford TB; Eccleston D; Guldberg HC
    Brain; 1970; 93(2):357-68. PubMed ID: 4912291
    [No Abstract]   [Full Text] [Related]  

  • 10. Biogenic amine disturbances in cerebrospinal fluid in parkinsonism and unipolar depression: use of the probenecid method.
    Vanderheyden JE; Noel G; Mendlewicz J
    Neuropsychobiology; 1981; 7(3):137-51. PubMed ID: 6164951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin and dopamine disturbances in patients with unipolar depression and Parkinsonism.
    Mendlewicz J; Vanderheyden JE; Noel G
    Adv Exp Med Biol; 1981; 133():753-67. PubMed ID: 6172024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid of patients with senile dementia, presenile dementia and parkinsonism.
    Gottfries CG; Gottfries I; Roos BE
    J Neurochem; 1969 Sep; 16(9):1341-5. PubMed ID: 5808100
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical measurements of central dopamine and 5-hydroxytryptamine metabolism: reliability and interpretation of cerebrospinal fluid acid monoamine metabolite measures.
    Bowers MB
    Neuropharmacology; 1972 Jan; 11(1):101-11. PubMed ID: 5060511
    [No Abstract]   [Full Text] [Related]  

  • 14. Depressed monoamine catabolite levels in cerebrospinal fluid of patients with parkinsonism dementia of Guam.
    Brody JA; Chase TN; Gordon EK
    N Engl J Med; 1970 Apr; 282(17):947-50. PubMed ID: 5436031
    [No Abstract]   [Full Text] [Related]  

  • 15. [Central metabolism of dopamine and serotonin. I. Determination of cerebrospinal fluid levels of HVA and 5-HIAA by the probenecid test (modified)].
    Carrieri P; Campanella G; Mandarini A; Orefice G; Buscaino GA
    Acta Neurol (Napoli); 1976; 31(5):558-64. PubMed ID: 1015382
    [No Abstract]   [Full Text] [Related]  

  • 16. Acid monoamine metabolites in the cerebrospinal fluid of Parkinsonian patients treated with levodopa alone or combined with a decarboxylase inhibitor.
    Rinne UK; Sonninen V; Siirtola T
    Eur Neurol; 1973; 9(6):349-62. PubMed ID: 4712542
    [No Abstract]   [Full Text] [Related]  

  • 17. Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies.
    Garelis E; Young SN; Lal S; Sourkes TL
    Brain Res; 1974 Oct; 79(1):1-8. PubMed ID: 4279131
    [No Abstract]   [Full Text] [Related]  

  • 18. Homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid related to rated mental and motor impairment in senile and presenile dementia.
    Gottfries CG; Gottfries I; Roos BE
    Acta Psychiatr Scand; 1970; 46(2):99-105. PubMed ID: 5478542
    [No Abstract]   [Full Text] [Related]  

  • 19. Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique.
    Goodwin FK; Post RM; Dunner DL; Gordon EK
    Am J Psychiatry; 1973 Jan; 130(1):73-9. PubMed ID: 4345466
    [No Abstract]   [Full Text] [Related]  

  • 20. Liquid chromatographic determination of homovanillic acid, 5-hydroxyindoleacetic acid and probenecid levels in human cerebrospinal fluid during probenecid test.
    Gagnieu MC; Menouni-Foray V; Guardiola P; Quincy C; Renaud B
    Clin Chim Acta; 1984 May; 139(1):1-12. PubMed ID: 6202442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.